A chemically-defined supplement that meets and exceeds the performance of FBS in cell culture.
We are a small, biotech startup company based in Bozeman, MT Our goal at PurCell Bio is to produce a chemically-defined, complete media supplement that eliminates the need for serum in cell culture.
Our founder and CEO, Elizabeth “Tess” Corbin, started the company in pursuit of her desire to help cure her son’s rare genetic disorder, homocystinuria. At the time of her son’s diagnosis, there was little that could be done. So, after she earned a bachelor’s degree in chemistry from Montana State University (MSU), she earned her doctorate in biochemistry and stepped into stem cell research to try and help find a way to treat her son’s disease.
Since then, she has been researching stem cells as well as the development of a chemically-defined media supplements for cell culture research. The goal she has in mind with the latter is accelerating the entrance of advanced human cellular therapies into clinical trials, possibly speeding the development of a cure for her son’s disease.
The chemically-defined media also plays into her stem cell research as well. Her long-term goal for this research is to reprogram a person’s own stem cells to produce the correct enzymes, but cannot currently be done with the available cell culture medias. If she could provide the necessary tools (i.e., a chemically-defined media), it could lead to a breakthrough that could cures an enzymatic disease like homocystinuria.
In short, our goal at PurCell Bio is to produce a chemically-defined, complete media supplement that eliminates the need for serum in cell culture. This is for the purpose of accelerating the development of human cellular therapies and induced stem cell research, ultimately with the hope of facilitating the development of cure for genetic enzymatic diseases like homocystinuria.